EQT Life Sciences

EQT Life Sciences, formerly Life Sciences Partners (LSP), is one of Europe's largest and most experienced life sciences venture capital investors, headquartered in Amsterdam with additional offices in Munich and Boston. The firm has a 30-year track record, having raised approximately €3.5 billion across 12 private funds and 3 investment strategies: Life Sciences Funds (LSP 1–7), focused on drug development at all stages; Health Economic Funds, targeting later-stage MedTech, digital health, and diagnostics; and a Dementia Fund for neurodegenerative disease drug development and medical technology. The most recent core fund, LSP 7 (launched 2021), closed at €1 billion. EQT Life Sciences targets innovative companies developing therapeutics, medical devices, diagnostics, and healthtech globally, with an investment range of €10M–€60M per deal. The team typically takes a leading role in investment syndicates and a board seat post-investment, providing strategic, clinical, operational, financial, and commercial support. Founders can submit investment opportunities by contacting the team via the EQT website.